Pharma Mar, S.A. (BME:PHM)

Pharma Mar Revenue

Pharma Mar had revenue of 42.90M EUR in the quarter ending March 31, 2026, with 10.40% growth. This brings the company's revenue in the last twelve months to 225.43M, up 28.27% year-over-year. In the year 2025, Pharma Mar had annual revenue of 221.39M with 26.61% growth.

• Revenue (ttm): 225.43M
• Revenue Growth: +28.27%
• P/S Ratio: 7.42
• Revenue / Employee: 446.40K
• Employees: 505
• Market Cap: 1.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	221.39M	46.54M	26.61%
Dec 31, 2024	174.86M	16.70M	10.56%
Dec 31, 2023	158.15M	-38.19M	-19.45%
Dec 31, 2022	196.34M	-33.49M	-14.57%
Dec 31, 2021	229.83M	-40.13M	-14.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error